Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients

Authors: Lucy J Campbell, Tracy Dew, Rashim Salota, Emily Cheserem, Lisa Hamzah, Fowzia Ibrahim, Pantelis A Sarafidis, Caje F Moniz, Bruce M Hendry, Mary Poulton, Roy A Sherwood, Frank A Post

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Chronic kidney disease is common in HIV positive patients and renal tubular dysfunction has been reported in those receiving combination antiretroviral therapy (cART). Tenofovir (TFV) in particular has been linked to severe renal tubular disease as well as proximal tubular dysfunction. Markedly elevated urinary concentrations of retinal-binding protein (RBP) have been reported in patients with severe renal tubular disease, and low-molecular-weight proteins (LMWP) such as RBP may be useful in clinical practice to assess renal tubular function in patients receiving TFV. We analysed 3 LMWP as well as protein and albumin in the urine of a sample of HIV positive patients.

Methods

In a cross-sectional fashion, total protein, albumin, RBP, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL) were quantified in random urine samples of 317 HIV positive outpatients and expressed as the ratio-to-creatinine (RBPCR, CCR and NGALCR). Exposure to cART was categorised as none, cART without TFV, and cART containing TFV and a non-nucleoside reverse-transcriptase-inhibitor (TFV/NNRTI) or TFV and a protease-inhibitor (TFV/PI).

Results

Proteinuria was present in 10.4 % and microalbuminuria in 16.7 % of patients. Albumin accounted for approximately 10 % of total urinary protein. RBPCR was within the reference range in 95 % of patients while NGALCR was elevated in 67 % of patients. No overall differences in urine protein, albumin, and LMWP levels were observed among patients stratified by cART exposure, although a greater proportion of patients exposed to TFV/PI had RBPCR >38.8 μg/mmol (343 μg/g) (p = 0.003). In multivariate analyses, black ethnicity (OR 0.43, 95 % CI 0.24, 0.77) and eGFR <75 mL/min/1.73 m2 (OR 3.54, 95 % CI 1.61, 7.80) were independently associated with upper quartile (UQ) RBPCR. RBPCR correlated well to CCR (r2 = 0.71), but not to NGALCR, PCR or ACR.

Conclusions

In HIV positive patients, proteinuria was predominantly of tubular origin and microalbuminuria was common. RBPCR in patients without overt renal tubular disease was generally within the reference range, including those receiving TFV. RBP therefore appears a promising biomarker for monitoring renal tubular function in patients receiving TFV and for distinguishing patients with normal tubular function or mild tubular dysfunction from those with severe renal tubular disease or Fanconi syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Post FA, Holt SG: Recent developments in HIV and the kidney. Curr Opin Infect Dis. 2009, 22 (1): 43-48. 10.1097/QCO.0b013e328320ffec.CrossRefPubMed Post FA, Holt SG: Recent developments in HIV and the kidney. Curr Opin Infect Dis. 2009, 22 (1): 43-48. 10.1097/QCO.0b013e328320ffec.CrossRefPubMed
2.
go back to reference Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS. 2004, 18 (3): 541-546. 10.1097/00002030-200402200-00022.CrossRefPubMed Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS. 2004, 18 (3): 541-546. 10.1097/00002030-200402200-00022.CrossRefPubMed
3.
go back to reference Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, et al: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004, 66 (3): 1145-1152. 10.1111/j.1523-1755.2004.00865.x.CrossRefPubMed Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, et al: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004, 66 (3): 1145-1152. 10.1111/j.1523-1755.2004.00865.x.CrossRefPubMed
4.
go back to reference Post FA, Campbell LJ, Hamzah L, Collins L, Jones R, Siwani R, Johnson L, Fisher M, Holt SG, Bhagani S, et al: Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis. 2008, 46 (8): 1282-1289. 10.1086/529385.CrossRefPubMed Post FA, Campbell LJ, Hamzah L, Collins L, Jones R, Siwani R, Johnson L, Fisher M, Holt SG, Bhagani S, et al: Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis. 2008, 46 (8): 1282-1289. 10.1086/529385.CrossRefPubMed
5.
go back to reference Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG: HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS. 2009, 23 (16): 2143-2149. 10.1097/QAD.0b013e3283313c91.CrossRefPubMedPubMedCentral Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG: HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS. 2009, 23 (16): 2143-2149. 10.1097/QAD.0b013e3283313c91.CrossRefPubMedPubMedCentral
6.
go back to reference El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, et al: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006, 355 (22): 2283-2296.CrossRefPubMed El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, et al: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006, 355 (22): 2283-2296.CrossRefPubMed
7.
go back to reference Reid A, Stohr W, Walker AS, Williams IG, Kityo C, Hughes P, Kambugu A, Gilks CF, Mugyenyi P, Munderi P, et al: Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008, 46 (8): 1271-1281. 10.1086/533468.CrossRefPubMed Reid A, Stohr W, Walker AS, Williams IG, Kityo C, Hughes P, Kambugu A, Gilks CF, Mugyenyi P, Munderi P, et al: Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008, 46 (8): 1271-1281. 10.1086/533468.CrossRefPubMed
8.
go back to reference Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. 2008, 22 (4): 481-487. 10.1097/QAD.0b013e3282f4706d.CrossRefPubMedPubMedCentral Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. 2008, 22 (4): 481-487. 10.1097/QAD.0b013e3282f4706d.CrossRefPubMedPubMedCentral
9.
go back to reference Longenecker CT, Scherzer R, Bacchetti P, Lewis CE, Grunfeld C, Shlipak MG: HIV viremia and changes in kidney function. AIDS. 2009, 23 (9): 1089-1096. 10.1097/QAD.0b013e32832a3f24.CrossRefPubMedPubMedCentral Longenecker CT, Scherzer R, Bacchetti P, Lewis CE, Grunfeld C, Shlipak MG: HIV viremia and changes in kidney function. AIDS. 2009, 23 (9): 1089-1096. 10.1097/QAD.0b013e32832a3f24.CrossRefPubMedPubMedCentral
10.
go back to reference Ibrahim F, Naftalin C, Cheserem E, Roe J, Campbell LJ, Bansi L, Hendry BM, Sabin C, Post FA: Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS. 2010, 24 (14): 2239-2244. 10.1097/QAD.0b013e32833c85d6.CrossRefPubMed Ibrahim F, Naftalin C, Cheserem E, Roe J, Campbell LJ, Bansi L, Hendry BM, Sabin C, Post FA: Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS. 2010, 24 (14): 2239-2244. 10.1097/QAD.0b013e32833c85d6.CrossRefPubMed
11.
go back to reference Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, Fine DM: Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006, 21 (10): 2809-2813. 10.1093/ndt/gfl337.CrossRefPubMed Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, Fine DM: Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006, 21 (10): 2809-2813. 10.1093/ndt/gfl337.CrossRefPubMed
12.
go back to reference Bansi L, Hughes A, Bhagani S, Mackie NE, Leen C, Levy J, Edwards S, Connolly J, Holt SG, Hendry BM, et al: Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS. 2009, 23 (18): 2517-2521. 10.1097/QAD.0b013e3283320e12.CrossRefPubMed Bansi L, Hughes A, Bhagani S, Mackie NE, Leen C, Levy J, Edwards S, Connolly J, Holt SG, Hendry BM, et al: Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS. 2009, 23 (18): 2517-2521. 10.1097/QAD.0b013e3283320e12.CrossRefPubMed
13.
go back to reference Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD: Chronic renal failure among HIV-1-infected patients. AIDS. 2007, 21 (9): 1119-1127. 10.1097/QAD.0b013e3280f774ee.CrossRefPubMed Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD: Chronic renal failure among HIV-1-infected patients. AIDS. 2007, 21 (9): 1119-1127. 10.1097/QAD.0b013e3280f774ee.CrossRefPubMed
14.
go back to reference Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD: Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010, 24 (11): 1667-1678. 10.1097/QAD.0b013e328339fe53.CrossRefPubMed Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD: Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010, 24 (11): 1667-1678. 10.1097/QAD.0b013e328339fe53.CrossRefPubMed
15.
go back to reference Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA: Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009, 10 (6): 329-336. 10.1111/j.1468-1293.2008.00691.x.CrossRefPubMed Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA: Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009, 10 (6): 329-336. 10.1111/j.1468-1293.2008.00691.x.CrossRefPubMed
16.
go back to reference Prevention and management of non-infectious co-morbidities in HIV. , , , http://www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/eacsguidelines-6.pdf Prevention and management of non-infectious co-morbidities in HIV. , , , http://​www.​europeanaidsclin​icalsociety.​org/​images/​stories/​EACS-Pdf/​eacsguidelines-6.​pdf
17.
go back to reference Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, et al: Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005, 40 (11): 1559-1585. 10.1086/430257.CrossRefPubMed Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, et al: Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005, 40 (11): 1559-1585. 10.1086/430257.CrossRefPubMed
18.
go back to reference Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, Geretti AM, Kelleher P, Mackie N, Muir D, et al: British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med. 2012, 13 (1): 1-44. 10.1111/j.1468-1293.2011.00971.x.CrossRefPubMed Asboe D, Aitken C, Boffito M, Booth C, Cane P, Fakoya A, Geretti AM, Kelleher P, Mackie N, Muir D, et al: British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med. 2012, 13 (1): 1-44. 10.1111/j.1468-1293.2011.00971.x.CrossRefPubMed
19.
go back to reference Izzedine H, Deray G: The nephrologist in the HAART era. AIDS. 2007, 21 (4): 409-421. 10.1097/QAD.0b013e328011ec40.CrossRefPubMed Izzedine H, Deray G: The nephrologist in the HAART era. AIDS. 2007, 21 (4): 409-421. 10.1097/QAD.0b013e328011ec40.CrossRefPubMed
20.
go back to reference Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G: Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis. 2006, 42 (2): 283-290. 10.1086/499048.CrossRefPubMed Zimmermann AE, Pizzoferrato T, Bedford J, Morris A, Hoffman R, Braden G: Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis. 2006, 42 (2): 283-290. 10.1086/499048.CrossRefPubMed
21.
go back to reference Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D, Edwards SG, Johnson MA, Connolly JO: Tenofovir-associated renal and bone toxicity. HIV Med. 2009, 10 (8): 482-487. 10.1111/j.1468-1293.2009.00716.x.CrossRefPubMed Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D, Edwards SG, Johnson MA, Connolly JO: Tenofovir-associated renal and bone toxicity. HIV Med. 2009, 10 (8): 482-487. 10.1111/j.1468-1293.2009.00716.x.CrossRefPubMed
22.
go back to reference Peyriere H, Reynes J, Rouanet I, Daniel N, de Boever CM, Mauboussin JM, Leray H, Moachon L, Vincent D, Salmon-Ceron D: Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr. 2004, 35 (3): 269-273. 10.1097/00126334-200403010-00007.CrossRefPubMed Peyriere H, Reynes J, Rouanet I, Daniel N, de Boever CM, Mauboussin JM, Leray H, Moachon L, Vincent D, Salmon-Ceron D: Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr. 2004, 35 (3): 269-273. 10.1097/00126334-200403010-00007.CrossRefPubMed
23.
go back to reference Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK, Launay-Vacher V, Deray G: Renal safety of tenofovir in HIV treatment-experienced patients. AIDS. 2004, 18 (7): 1074-1076. 10.1097/00002030-200404300-00019.CrossRefPubMed Izzedine H, Isnard-Bagnis C, Hulot JS, Vittecoq D, Cheng A, Jais CK, Launay-Vacher V, Deray G: Renal safety of tenofovir in HIV treatment-experienced patients. AIDS. 2004, 18 (7): 1074-1076. 10.1097/00002030-200404300-00019.CrossRefPubMed
24.
go back to reference Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, Rivas P, Albalater M, Blanco F, Moreno V, et al: Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS. 2009, 23 (6): 689-696. 10.1097/QAD.0b013e3283262a64.CrossRefPubMed Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, Rivas P, Albalater M, Blanco F, Moreno V, et al: Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS. 2009, 23 (6): 689-696. 10.1097/QAD.0b013e3283262a64.CrossRefPubMed
25.
go back to reference Hall AM, Edwards SG, Lapsley M, Connolly JO, Chetty K, O'Farrell S, Unwin RJ, Williams IG: Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis. 2009, 54 (6): 1034-1042. 10.1053/j.ajkd.2009.07.012.CrossRefPubMed Hall AM, Edwards SG, Lapsley M, Connolly JO, Chetty K, O'Farrell S, Unwin RJ, Williams IG: Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis. 2009, 54 (6): 1034-1042. 10.1053/j.ajkd.2009.07.012.CrossRefPubMed
26.
go back to reference Fux C, Opravil M, Cavassini M, Calmy A, Flepp M, Gurtner-Delafuente V, Stoeckle M, Schmid P, Rauch A, Furrer H, et al: 16th Conference on Retroviruses and Opportunistic Infections. Tenofovir and PI Use Are Associated with an Increased Prevalence of Proximal Renal Tubular Dysfunction in the Swiss HIV Cohort Study. 2009, Montreal, Canada Fux C, Opravil M, Cavassini M, Calmy A, Flepp M, Gurtner-Delafuente V, Stoeckle M, Schmid P, Rauch A, Furrer H, et al: 16th Conference on Retroviruses and Opportunistic Infections. Tenofovir and PI Use Are Associated with an Increased Prevalence of Proximal Renal Tubular Dysfunction in the Swiss HIV Cohort Study. 2009, Montreal, Canada
27.
go back to reference Rodriguez-Novoa S, Labarga P, Soriano V, Egan D, Albalater M, Morello J, Cuenca L, Gonzalez-Pardo G, Khoo S, Back D, et al: Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis. 2009, 48 (11): e108-116. 10.1086/598507.CrossRefPubMed Rodriguez-Novoa S, Labarga P, Soriano V, Egan D, Albalater M, Morello J, Cuenca L, Gonzalez-Pardo G, Khoo S, Back D, et al: Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis. 2009, 48 (11): e108-116. 10.1086/598507.CrossRefPubMed
28.
go back to reference Rodriguez-Novoa S, Labarga P, D'Avolio A, Barreiro P, Albalate M, Vispo E, Solera C, Siccardi M, Bonora S, Di Perri G, et al: Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS. 2010, 24 (7): 1064-1066. 10.1097/QAD.0b013e32833202e2.CrossRefPubMed Rodriguez-Novoa S, Labarga P, D'Avolio A, Barreiro P, Albalate M, Vispo E, Solera C, Siccardi M, Bonora S, Di Perri G, et al: Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS. 2010, 24 (7): 1064-1066. 10.1097/QAD.0b013e32833202e2.CrossRefPubMed
29.
go back to reference Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K: Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant. 2011, 26 (10): 3224-3229. 10.1093/ndt/gfr020.CrossRefPubMed Ando M, Yanagisawa N, Ajisawa A, Tsuchiya K, Nitta K: Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant. 2011, 26 (10): 3224-3229. 10.1093/ndt/gfr020.CrossRefPubMed
30.
go back to reference Post FA, Moyle GJ, Stellbrink HJ, Domingo P, Podzamczer D, Fisher M, Norden AG, Cavassini M, Rieger A, Khuong-Josses MA, et al: Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: 48-Week Results From the ASSERT Study. J Acquir Immune Defic Syndr. 2010, 55 (1): 49-57. 10.1097/QAI.0b013e3181dd911e.CrossRefPubMed Post FA, Moyle GJ, Stellbrink HJ, Domingo P, Podzamczer D, Fisher M, Norden AG, Cavassini M, Rieger A, Khuong-Josses MA, et al: Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: 48-Week Results From the ASSERT Study. J Acquir Immune Defic Syndr. 2010, 55 (1): 49-57. 10.1097/QAI.0b013e3181dd911e.CrossRefPubMed
31.
go back to reference Horberg M, Tang B, Towner W, Silverberg M, Bersoff-Matcha S, Hurley L, Chang J, Blank J, Quesenberry C, Klein D: Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010, 53 (1): 62-69. 10.1097/QAI.0b013e3181be6be2.CrossRefPubMed Horberg M, Tang B, Towner W, Silverberg M, Bersoff-Matcha S, Hurley L, Chang J, Blank J, Quesenberry C, Klein D: Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010, 53 (1): 62-69. 10.1097/QAI.0b013e3181be6be2.CrossRefPubMed
32.
go back to reference Pushpakom SP, Liptrott NJ, Rodriguez-Novoa S, Labarga P, Soriano V, Albalater M, Hopper-Borge E, Bonora S, Di Perri G, Back DJ, et al: Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction. J Infect Dis. 2011, 204 (1): 145-153. 10.1093/infdis/jir215.CrossRefPubMedPubMedCentral Pushpakom SP, Liptrott NJ, Rodriguez-Novoa S, Labarga P, Soriano V, Albalater M, Hopper-Borge E, Bonora S, Di Perri G, Back DJ, et al: Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction. J Infect Dis. 2011, 204 (1): 145-153. 10.1093/infdis/jir215.CrossRefPubMedPubMedCentral
33.
go back to reference Jaafar A, Seronie-Vivien S, Malard L, Massip P, Chatelut E, Tack I: Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients. AIDS. 2009, 23 (2): 257-259. 10.1097/QAD.0b013e328314e382.CrossRefPubMed Jaafar A, Seronie-Vivien S, Malard L, Massip P, Chatelut E, Tack I: Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients. AIDS. 2009, 23 (2): 257-259. 10.1097/QAD.0b013e328314e382.CrossRefPubMed
34.
go back to reference Post FA, Wyatt CM, Mocroft A: Biomarkers of impaired renal function. Curr Opin HIV AIDS. 2010, 5 (6): 524-530. 10.1097/COH.0b013e32833f203e.CrossRefPubMed Post FA, Wyatt CM, Mocroft A: Biomarkers of impaired renal function. Curr Opin HIV AIDS. 2010, 5 (6): 524-530. 10.1097/COH.0b013e32833f203e.CrossRefPubMed
35.
go back to reference Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005, 365 (9466): 1231-1238. 10.1016/S0140-6736(05)74811-X.CrossRefPubMed Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005, 365 (9466): 1231-1238. 10.1016/S0140-6736(05)74811-X.CrossRefPubMed
36.
go back to reference Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007, 25 (6): 1105-1187. 10.1097/HJH.0b013e3281fc975a.CrossRefPubMed Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007, 25 (6): 1105-1187. 10.1097/HJH.0b013e3281fc975a.CrossRefPubMed
37.
go back to reference Sola-Del Valle DA, Mohan S, Cheng JT, Paragas NA, Sise ME, D'Agati VD, Barasch J: Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant. 2011, 26 (7): 2387-2390. 10.1093/ndt/gfr258.CrossRefPubMedPubMedCentral Sola-Del Valle DA, Mohan S, Cheng JT, Paragas NA, Sise ME, D'Agati VD, Barasch J: Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant. 2011, 26 (7): 2387-2390. 10.1093/ndt/gfr258.CrossRefPubMedPubMedCentral
38.
go back to reference Paragas N, Nickolas TL, Wyatt C, Forster CS, Sise M, Morgello S, Jagla B, Buchen C, Stella P, Sanna-Cherchi S, et al: Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol. 2009, 20 (8): 1687-1692. 10.1681/ASN.2009010065.CrossRefPubMedPubMedCentral Paragas N, Nickolas TL, Wyatt C, Forster CS, Sise M, Morgello S, Jagla B, Buchen C, Stella P, Sanna-Cherchi S, et al: Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol. 2009, 20 (8): 1687-1692. 10.1681/ASN.2009010065.CrossRefPubMedPubMedCentral
39.
go back to reference Han TM, Naicker S, Ramdial PK, Assounga AG: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006, 69 (12): 2243-2250. 10.1038/sj.ki.5000339.CrossRefPubMed Han TM, Naicker S, Ramdial PK, Assounga AG: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006, 69 (12): 2243-2250. 10.1038/sj.ki.5000339.CrossRefPubMed
40.
go back to reference Izzedine H, Hulot JS, Villard E, Goyenvalle C, Dominguez S, Ghosn J, Valantin MA, Lechat P, Deray AG: Association between ABCC2 Gene Haplotypes and Tenofovir-Induced Proximal Tubulopathy. J Infect Dis. 2006, 194 (11): 1481-1491. 10.1086/508546.CrossRefPubMed Izzedine H, Hulot JS, Villard E, Goyenvalle C, Dominguez S, Ghosn J, Valantin MA, Lechat P, Deray AG: Association between ABCC2 Gene Haplotypes and Tenofovir-Induced Proximal Tubulopathy. J Infect Dis. 2006, 194 (11): 1481-1491. 10.1086/508546.CrossRefPubMed
41.
go back to reference Burling KA, Cutillas PR, Church D, Lapsley M, Norden AG: Analysis of molecular forms of urine Retinol-Binding Protein in Fanconi Syndrome and design of an accurate immunoassay. Clin Chim Acta. 2012, 413 (3–4): 483-489.CrossRefPubMed Burling KA, Cutillas PR, Church D, Lapsley M, Norden AG: Analysis of molecular forms of urine Retinol-Binding Protein in Fanconi Syndrome and design of an accurate immunoassay. Clin Chim Acta. 2012, 413 (3–4): 483-489.CrossRefPubMed
42.
go back to reference Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG: Microalbuminuria in HIV infection. AIDS. 2007, 21 (8): 1003-1009. 10.1097/QAD.0b013e3280d3587f.CrossRefPubMedPubMedCentral Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG: Microalbuminuria in HIV infection. AIDS. 2007, 21 (8): 1003-1009. 10.1097/QAD.0b013e3280d3587f.CrossRefPubMedPubMedCentral
43.
go back to reference Sarafidis PA, Bakris GL: Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant. 2006, 21 (9): 2366-2374. 10.1093/ndt/gfl309.CrossRefPubMed Sarafidis PA, Bakris GL: Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant. 2006, 21 (9): 2366-2374. 10.1093/ndt/gfl309.CrossRefPubMed
44.
go back to reference Gardner LI, Holmberg SD, Williamson JM, Szczech LA, Carpenter CC, Rompalo AM, Schuman P, Klein RS: Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003, 32 (2): 203-209. 10.1097/00126334-200302010-00013.CrossRefPubMed Gardner LI, Holmberg SD, Williamson JM, Szczech LA, Carpenter CC, Rompalo AM, Schuman P, Klein RS: Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003, 32 (2): 203-209. 10.1097/00126334-200302010-00013.CrossRefPubMed
45.
go back to reference Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG: Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010, 121 (5): 651-658. 10.1161/CIRCULATIONAHA.109.898585.CrossRefPubMedPubMedCentral Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG: Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010, 121 (5): 651-658. 10.1161/CIRCULATIONAHA.109.898585.CrossRefPubMedPubMedCentral
46.
go back to reference George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG: Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS. 2010, 24 (3): 387-394. 10.1097/QAD.0b013e3283359253.CrossRefPubMedPubMedCentral George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG: Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS. 2010, 24 (3): 387-394. 10.1097/QAD.0b013e3283359253.CrossRefPubMedPubMedCentral
47.
go back to reference Wyatt CM, Hoover DR, Shi Q, Seaberg E, Wei C, Tien PC, Karim R, Lazar J, Young MA, Cohen MH: Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr. 2010, 55 (1): 73-77. 10.1097/QAI.0b013e3181cc1070.CrossRefPubMedPubMedCentral Wyatt CM, Hoover DR, Shi Q, Seaberg E, Wei C, Tien PC, Karim R, Lazar J, Young MA, Cohen MH: Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr. 2010, 55 (1): 73-77. 10.1097/QAI.0b013e3181cc1070.CrossRefPubMedPubMedCentral
Metadata
Title
Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients
Authors
Lucy J Campbell
Tracy Dew
Rashim Salota
Emily Cheserem
Lisa Hamzah
Fowzia Ibrahim
Pantelis A Sarafidis
Caje F Moniz
Bruce M Hendry
Mary Poulton
Roy A Sherwood
Frank A Post
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-85

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.